CD38 deficiency in the tumor microenvironment attenuates glioma progression and modulates features of tumor-associated microglia/macrophages

Neuro-Oncology

Volumn 14, Issue 8, 2012, Pages 1037-1049

  Levy, Ayelet ^a   Blacher, Eran ^a   Vaknine, Hananya ^b   Lund, Frances E ^c   Stein, Reuven ^a   Mayo, Lior ^a,d  

^a TEL AVIV UNIVERSITY   (Israel)

^b WOLFSON MEDICAL CENTER   (Israel)

^c UNIVERSITY OF ROCHESTER MEDICAL CENTER   (United States)

^d HARVARD MEDICAL SCHOOL   (United States)

Author keywords

brain; cancer; CD38; glioma; microglia

Indexed keywords

CD38 ANTIGEN; MACROPHAGE ELASTASE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CANCER INHIBITION; CELL DEATH; CELL EXPANSION; CONTROLLED STUDY; DISEASE COURSE; GLIOMA; LIFESPAN; MALE; MOUSE; NONHUMAN; PROTEIN EXPRESSION; TUMOR ASSOCIATED LEUKOCYTE; TUMOR MICROENVIRONMENT; TUMOR VOLUME; WILD TYPE;

ANIMALS; ANTIGENS, CD38; BRAIN NEOPLASMS; CELL SEPARATION; DISEASE MODELS, ANIMAL; DISEASE PROGRESSION; FLOW CYTOMETRY; GLIOMA; IMMUNOBLOTTING; IMMUNOHISTOCHEMISTRY; MACROPHAGES; MALE; MEMBRANE GLYCOPROTEINS; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; MICROGLIA; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; TUMOR MICROENVIRONMENT;

EID: 84864699888     PISSN: 15228517     EISSN: 15235866     Source Type: Journal    
DOI: 10.1093/neuonc/nos121     Document Type: Article

References (39)

1. Badie B, Schartner J. Role of microglia in glioma biology. Microsc Res Tech. 2001;54:106-113.
2. Rivest S. Regulation of innate immune responses in the brain. Nat Rev Immunol. 2009;9:429-439.
3. Watters JJ, Schartner JM, Badie B. Microglia function in brain tumors. J Neurosci Res. 2005;81:447-455.
4. Yang I, Han SJ, Kaur G, Crane C, Parsa AT. The role of microglia in central nervous system immunity and glioma immunology. J Clin Neurosci. 2010;17:6-10.
5. Markovic DS, Glass R, Synowitz M, Rooijen N, Kettenmann H. Microglia stimulate the invasiveness of glioma cells by increasing the activity of metalloprotease-2. J Neuropathol Exp Neurol. 2005;64:754-762.
6. Markovic DS, Vinnakota K, Chirasani S, et al. Gliomas induce and exploit microglial MT1-MMP expression for tumor expansion. Proc Natl Acad Sci USA. 2009;106:12530-12535.
7. Mayo L, Jacob-Hirsch J, Amariglio N, et al. Dual role of CD38 in microglial activation and activation-induced cell death. J Immunol. 2008; 181:92-103.
8. Partida-Sanchez S, Iribarren P, Moreno-Garcia ME, et al. Chemotaxis and calcium responses of phagocytes to formyl peptide receptor ligands is differentially regulated by cyclic ADP ribose. J Immunol. 2004;172:1896-1906.
9. Franco L, Bodrato N, Moreschi I, et al. Cyclic ADP-ribose is a second messenger in the lipopolysaccharide-stimulated activation of murine N9 microglial cell line. J Neurochem. 2006;99:165-176.
10. Levy A, Bercovich-Kinori A, Alexandrovich AG, et al. CD38 facilitates recovery from traumatic brain injury. J Neurotrauma. 2009;26: 1521-1533.
11. Malavasi F, Deaglio S, Funaro A, et al. Evolution and function of the ADP ribosyl cyclase/CD38 gene family in physiology and pathology. Physiol Rev. 2008;88:841-886.
12. Partida-Sanchez S, Rivero-Nava L, Shi G, Lund FE. CD38: An ecto-enzyme at the crossroads of innate and adaptive immune responses. Adv Exp Med Biol. 2007;590:171-183.
13. Partida-Sanchez S, Cockayne DA, Monard S, et al. Cyclic ADP-ribose production by CD38 regulates intracellular calcium release, extracellular calcium influx and chemotaxis in neutrophils and is required for bacterial clearance in vivo. Nat Med. 2001;7:1209-1216.
14. Guedes AG, Paulin J, Rivero-Nava L, Kita H, Lund FE, Kannan MS. CD38-deficient mice have reduced airway hyperresponsiveness following IL-13 challenge. Am J Physiol Lung Cell Mol Physiol. 2006;291:L1286-L1293.
15. Kato I, Yamamoto Y, Fujimura M, Noguchi N, Takasawa S, Okamoto H. CD38 disruption impairs glucose-induced increases in cyclic ADP-ribose, [Ca2 + ]i, and insulin secretion. J Biol Chem. 1999;274:1869-1872.
16. Sun L, Iqbal J, Dolgilevich S, et al. Disordered osteoclast formation and function in a CD38 (ADP-ribosyl cyclase)-deficient mouse establishes an essential role for CD38 in bone resorption. FASEB J. 2003;17:369-375.
17. Jin D, Liu HX, Hirai H, et al. CD38 is critical for social behaviour by regulating oxytocin secretion. Nature. 2007;446:41-45.
18. Partida-Sanchez S, Randall TD, Lund FE. Innate immunity is regulated by CD38, an ecto-enzyme with ADP-ribosyl cyclase activity. Microbes Infect. 2003;5:49-58.
19. Malavasi F, Deaglio S, Damle R, Cutrona G, Ferrarini M, Chiorazzi N. CD38 and chronic lymphocytic leukemia: A decade later. Blood. 2011;118:3470-3478.
20. Cockayne DA, Muchamuel T, Grimaldi JC, et al. Mice deficient for the ecto-nicotinamide adenine dinucleotide glycohydrolase CD38 exhibit altered humoral immune responses. Blood. 1998;92:1324-1333.
21. Krebs C, Adriouch S, Braasch F, et al. CD38 controls ADPribosyltransferase- 2-catalyzed ADP-ribosylation of T cell surface proteins. J Immunol. 2005;174:3298-3305.
22. Miyoshi H, Takahashi M, Gage FH, Verma IM. Stable and efficient gene transfer into the retina using an HIV-based lentiviral vector. Proc Natl Acad Sci USA. 1997;94:10319-10323.
23. Matsumori Y, Hong SM, Fan Y, et al. Enriched environment and spatial learning enhance hippocampal neurogenesis and salvages ischemic penumbra after focal cerebral ischemia. Neurobiol Dis. 2006;22:187-198.
24. Cardona AE, Huang D, Sasse ME, Ransohoff RM. Isolation of murine microglial cells for RNA analysis or flow cytometry. Nat Protoc. 2006;1:1947-1951.
25. Hickman SE, Allison EK, El Khoury J. Microglial dysfunction and defective beta-amyloid clearance pathways in aging Alzheimer's disease mice. J Neurosci. 2008;28:8354-8360.
26. Livak KJ, Schmittgen TD. Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) m vb nbethod. Methods. 2001;25:402-408.
27. Lukasiak S, Breuhahn K, Schiller C, Schmidtke G, Groettrup M. Quantitative analysis of gene expression relative to 18S rRNA in carcinoma samples using the LightCycler instrument and a SYBR GreenI-based assay: Determining FAT10 mRNA levels in hepatocellular carcinoma. Methods Mol Biol. 2008;429:59-72.
28. Dixon WJ, Massey FJ. Introduction to Statistical Analysis. 1st ed. New York: McGraw-Hill; 1951.
29. Newcomb EW, Zagzag D. The murine GL261 glioma experimental model to assess novel brain tumor treatments. In: Meir, EG, ed. CNS Cancer: Models, Markers, Prognostic Factors, Targets and Therapeutic Approaches. Dordrecht: Springer. 2009:227-241.
30. Szatmari T, Lumniczky K, Desaknai S, et al. Detailed characterization of the mouse glioma 261 tumor model for experimental glioblastoma therapy. Cancer Sci. 2006;97:546-553.
31. Folkman J. Tumor angiogenesis: Therapeutic implications. N Engl J Med. 1971;285:1182-1186.
32. Nakada M, Okada Y, Yamashita J. The role of matrix metalloproteinases in glioma invasion. Front Biosci. 2003;8:e261-e269.
33. Sarkar S, Nuttall RK, Liu S, Edwards DR, Yong VW. Tenascin-C stimulates glioma cell invasion through matrix metalloproteinase-12. Cancer Res. 2006;66:11771-11780.
34. Belaaouaj A, Shipley JM, Kobayashi DK, et al. Human macrophage metalloelastase. Genomic organization, chromosomal location, gene linkage, and tissue-specific expression. J Biol Chem. 1995;270: 14568-14575.
35. Yeh WL, Lu DY, Lee MJ, Fu WM. Leptin induces migration and invasion of glioma cells through MMP-13 production. Glia. 2009;57: 454-464.
36. Chini EN. CD38 as a regulator of cellular NAD: A novel potential pharmacological target for metabolic conditions. Curr Pharm Des. 2009;15:57-63.
37. Adriouch S, Hubert S, Pechberty S, Koch-Nolte F, Haag F, Seman M. NAD + released during inflammation participates in T cell homeostasis by inducing ART2-mediated death of naive T cells in vivo. J Immunol. 2007;179:186-194.
38. Ying W. NAD + /NADH and NADP + /NADPH in cellular functions and cell death: regulation and biological consequences. Antioxid Redox Signal. 2008;10:179-206.
39. Barcellos-Hoff MH, Newcomb EW, Zagzag D, Narayana A. Therapeutic targets in malignant glioblastoma microenvironment. Semin Radiat Oncol. 2009;19:163-170.